Sr. FP&A Analyst at Abbott

Taipei City, Taipei City, Taiwan

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Medical Devices, HealthcareIndustries

Requirements

Bachelor’s degree in Finance, Accounting, Business Administration, or related field. MBA/CPA preferred
3+ years in FP&A, corporate finance, or auditing (medical device/pharma industry a plus)
Proficiency in Excel, ERP systems (SAP), and BI tools (Power BI)
Strong analytical and problem-solving abilities
Fluent in English and Mandarin (written/spoken) for cross-regional collaboration
Ability to communicate complex financial data to non-finance stakeholders
Knowledge of Vascular’s products (stents, vascular devices) and Taiwan’s healthcare market (preferred)

Responsibilities

Prepare annual budgets, forecasts, and long-range plans (LRP) in alignment with corporate goals
Analyze financial performance (P&L, balance sheet, cash flow) and provide actionable insights to management
Track KPIs (sales, margins, OPEX) and identify risks/opportunities
Generate monthly/quarterly financial reports for regional and global teams
Consolidate and analyze divisional performance vs. targets
Support ad-hoc financial presentations for senior leadership
Collaborate with commercial, supply chain, and marketing teams to evaluate business cases (e.g., pricing, investments, ROI)
Provide cost analysis and scenario modeling for strategic initiatives

Skills

Excel

SAP

Power BI

Financial Planning

Budgeting

Forecasting

Financial Reporting

KPI Analysis

P&L Analysis

Scenario Modeling

ROI Analysis

Abbott

Healthcare solutions in diagnostics and devices

About Abbott

Abbott Laboratories focuses on improving health through various medical technologies and health solutions. The company operates in areas such as cardiovascular health, diabetes management, diagnostic testing, nutrition, and neuromodulation for chronic pain and movement disorders. Abbott's products include advanced medical devices and diagnostic tests that help healthcare professionals and patients manage health conditions effectively. For example, their cardiovascular technologies assist in heart health management, while diabetes care products enable accurate glucose monitoring without painful fingersticks. Unlike many competitors, Abbott emphasizes accessibility and affordability in its offerings, aiming to make life-changing technologies available to a broader audience. The company's goal is to positively impact global health and well-being, supported by a commitment to sustainability and a 2030 Sustainability Plan.

Lake Bluff, IllinoisHeadquarters

1888Year Founded

IPOCompany Stage

HealthcareIndustries

10,001+Employees

Risks

Departure of key leader Dr. Adamson may affect Abbott's Heart Failure division.

Integration challenges with Medtronic could impact glucose monitor-insulin pump rollout.

Thermo Fisher's microfluidics expansion may increase competition for Abbott.

Differentiation

Abbott integrates continuous glucose monitoring with automated insulin delivery systems.

Abbott's microfluidic devices streamline diagnostic processes efficiently.

Abbott's neuromodulation products target specific nervous system areas for chronic pain relief.

Upsides

Microfluidic technology offers cost-effective solutions in diagnostics.

Strategic partnerships like Abbott-Medtronic enhance product offerings and market reach.

Significant investments indicate strong market confidence in Abbott's healthcare solutions.

Land your dream remote job 3x faster with AI

Try Jobo Free